CClinicalTrials.gg
TerminatedNCT01810263Updated Jul 2, 2015Results posted

The Efficacy of Intensive Nutritional Supplement in Patient With Stroke

A Phase 2/3 interventional study of high protein supplement in Stroke and Malnutrition, sponsored by Seoul National University Bundang Hospital. Terminated at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2015-07-02.

Sponsored by Seoul National University Bundang Hospital · Phase 2/3, Interventional, and Treatment

Why this study was terminated
The study does not seem to provide benefits to patients.
Phase
Phase 2/3
Study type
Interventional
Enrollment
34
Allocation
Randomized
Sex
All
01

Study summary

The aim of this prospective randomized controlled study is to demonstrate the efficacy of Intensive Nutritional Supplement in Patient with Stroke.

Read the detailed description

Elderly patients, including those who have had a stroke, are more at risk of undernutrition than other groups because of reduced nutritional reserves, prolonged hospital stay and increased demands of repeated ill-health. Stroke may compound these problems because of physical and mental incapacity, problems with perception and communication, and swallowing disorders. The full extent of undernutrition and its independent contribution to stroke outcome is not presently known. It is also not known whether it can be corrected, and whether doing so would improve the outcome. The aim of this study is therefore to describe the efficacy of Intensive Nutritional Supplement in Patient with Stroke.

02

Conditions studied

  • Stroke
  • Malnutrition

Keywords

  • stroke
  • malnutrition
  • high protein
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,013 are open to participants now.

This study's enrollment of 34 is below the median of 50 across 5,366 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Seoul National University Bundang Hospital is the lead sponsor of 368 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 1 st onset stroke patient
  • MRI confirms his/her stroke
  • more than 2.5% weight los within 2 weeks
  • initial serum albumin \< 35 g/l
  • BMI \< 18.5
  • more than MMSE 10
  • medically stable

Exclusion criteria

Exclusion Criteria:

  • recurrent stroke patient
  • malabsorption patient
  • terminal cancer
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    high protein supplement

    high protein supplement given

    Dietary Supplement: high protein supplement

  • No intervention
    Control

    no intervention

Interventions

  • Dietary supplementhigh protein supplement

    Dietary Supplement: high protein supplement

    Also known as: Intensive Nutritional Supplement group

06

What researchers measure

Primary outcomes

  1. Modified Barthel Index (MBI) Score at 6 Months

    Scale range: 0-100 (higher values represent a better outcome)

    Time frame: 6 months

Secondary outcomes

  1. Chemical Laboratory Findings

    Time frame: 6 months

Other outcomes

  1. Body Mass Index

    Time frame: 6 months

  2. Triceps Skin Fold Thickness

    Time frame: 6 months

  3. Subjective Global Assessment

    Time frame: 6 months

07

Results

Posted Jul 2, 2015

Participant flow

* first ever stroke * MRI confirms his/her stroke * weight loss over 2.5% within 2 weeks after the stroke onset * MMSE \>= 10 * medically stable

Participant flow — Overall Study
MilestoneHigh Protein SupplementControl
Started1618
Completed811
Not completed87
Withdrew: Lost to follow-up87

Outcome measures

PrimaryModified Barthel Index (MBI) Score at 6 Months

Scale range: 0-100 (higher values represent a better outcome)

Time frame:
6 months
Reported as:
Mean · units on a scale
Modified Barthel Index (MBI) Score at 6 Months
units on a scaleHigh Protein SupplementControl
Modified Barthel Index (MBI) Score at 6 Months23.3 ± 2.721.9 ± 2.7
SecondaryChemical Laboratory Findings
Time frame:
6 months

Results for this outcome have not been posted.

Other pre-specifiedBody Mass Index
Time frame:
6 months

Results for this outcome have not been posted.

Other pre-specifiedTriceps Skin Fold Thickness
Time frame:
6 months

Results for this outcome have not been posted.

Other pre-specifiedSubjective Global Assessment
Time frame:
6 months

Results for this outcome have not been posted.

Adverse events

Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
High Protein Supplement—0/16 (0%)0/16 (0%)
Control—0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)High Protein SupplementControlTotal
Mean62.8 ± 16.065.8 ± 14.364.4 ± 15.2
Sex: Female, Male
Sex: Female, Male(Participants)High Protein SupplementControlTotal
Female9716
Male71118
Region of Enrollment
Region of Enrollment(participants)High Protein SupplementControlTotal
Korea, Republic of161834
08

Study locations

1 site
  • Seoul National University Bundang Hospital
    Seongnam-si, Korea, Gyeonggi-do 463-707, Korea, Republic of
09

References and documents

Publications

  • Gariballa SE, Parker SG, Taub N, Castleden M. Nutritional status of hospitalized acute stroke patients. Br J Nutr. 1998 Jun;79(6):481-7. doi: 10.1079/bjn19980085. PubMed 9771334 ↗
  • Axelsson K, Asplund K, Norberg A, Alafuzoff I. Nutritional status in patients with acute stroke. Acta Med Scand. 1988;224(3):217-24. doi: 10.1111/j.0954-6820.1988.tb19364.x. PubMed 3239449 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01810263
Lead sponsor
Seoul National University Bundang Hospital
Collaborators
Myongji Hospital
Responsible party
Nam-Jong Paik (professor, Seoul National University Bundang Hospital) — Principal investigator
First posted
Mar 13, 2013
Start date
May 2012
Primary completion
Jul 2014
Completion
Jul 2014
Results posted
Jul 2, 2015
Last update
Jul 2, 2015

Study contacts

Nam-Jong Paik, MD, PhD
principal investigator · Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion